BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 14603044)

  • 41. Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study.
    Wu HP; Chou YF; Yu SH; Wang CP; Hsu CJ; Chen PR
    Otol Neurotol; 2011 Jul; 32(5):774-9. PubMed ID: 21646929
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Three-dimensional (3D) visualization of endolymphatic hydrops after intratympanic injection of Gd-DTPA: optimization of a 3D-real inversion-recovery turbo spin-echo (TSE) sequence and application of a 32-channel head coil at 3T.
    Naganawa S; Ishihara S; Iwano S; Sone M; Nakashima T
    J Magn Reson Imaging; 2010 Jan; 31(1):210-4. PubMed ID: 20027590
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unusual cases of delayed endolymphatic hydrops.
    Albernaz PL
    Acta Otolaryngol; 2007 Apr; 127(4):355-9. PubMed ID: 17453453
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Summating potential and action potential ratio in Meniere's disease before and after treatment.
    Orchik DJ; Shea JJ; Ge NN
    Am J Otol; 1998 Jul; 19(4):478-82; discussion 483. PubMed ID: 9661758
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
    Perez N; Boleas MS; Martin E
    Audiol Neurootol; 2005; 10(2):69-78. PubMed ID: 15650298
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dose Effect of Intratympanic Dexamethasone for Idiopathic Sudden Sensorineural Hearing Loss: 24 mg/mL Is Superior to 10 mg/mL.
    Alexander TH; Harris JP; Nguyen QT; Vorasubin N
    Otol Neurotol; 2015 Sep; 36(8):1321-7. PubMed ID: 26196209
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Electrocochleography.
    Kumagami H; Nakata T; Hirano Y; Tsukazaki N
    Adv Otorhinolaryngol; 1997; 53():1-20. PubMed ID: 9226045
    [No Abstract]   [Full Text] [Related]  

  • 48. Endolymphatic hydrops in asymptomatic ears in unilateral Ménière's disease.
    Friedrichs I; Thornton AR
    Laryngoscope; 2001 May; 111(5):857-60. PubMed ID: 11359166
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Results of electrocochleography in Ménière's disease after successful vertigo control by single intratympanic gentamicin injection.
    Büki B; Platz M; Haslwanter T; Jünger H; Avan P
    Audiol Neurootol; 2011; 16(1):49-54. PubMed ID: 20523039
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosis of cochlear Ménière's disease with electrocochleography.
    Dornhoffer JL
    ORL J Otorhinolaryngol Relat Spec; 1998; 60(6):301-5. PubMed ID: 9742276
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Histopathology of Ménière's disease.
    Sennaroolu L; Linthicum FH
    Am J Otol; 2000 Nov; 21(6):889. PubMed ID: 11078081
    [No Abstract]   [Full Text] [Related]  

  • 52. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
    Fetterman BL
    Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical application of transiently evoked otoacoustic emissions after glycerol administration for diagnosis of sensorineural hearing loss.
    Inoue Y; Kanzaki J; O-Uchi T; Ogawa K; Ogata A; Yoshihara S; Satoh Y
    Auris Nasus Larynx; 1997 Apr; 24(2):143-9. PubMed ID: 9134136
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The correlation analysis of the cochlear hydrops degree found by MRI angiography with Meiniere's disease classification].
    Chen CJ; Chen ZN; Lu W; Wu YQ; Wang H; Shi HB; Yin SK
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Apr; 31(8):623-626. PubMed ID: 29871329
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparison of intermittent intratympanic steroid injection and near-continual transtympanic steroid perfusion as salvage treatments for sudden sensorineural hearing loss.
    Chou YF; Chen PR; Kuo IJ; Yu SH; Wen YH; Wu HP
    Laryngoscope; 2013 Sep; 123(9):2264-9. PubMed ID: 23804460
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hearing results and quality of life after streptomycin/dexamethasone perfusion for Meniere's disease.
    Shea PF; Richey PA; Wan JY; Stevens SR
    Laryngoscope; 2012 Jan; 122(1):204-11. PubMed ID: 22183636
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of acute low-tone sensorineural hearing loss versus Meniere's disease by electrocochleography.
    Noguchi Y; Nishida H; Tokano H; Kawashima Y; Kitamura K
    Ann Otol Rhinol Laryngol; 2004 Mar; 113(3 Pt 1):194-9. PubMed ID: 15053200
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intratympanic steroids injection is effective for the treatment of drop attacks with Ménière's disease and delayed endolymphatic hydrops: A retrospective study.
    Liu B; Leng Y; Zhou R; Liu J; Liu D; Zhang SL; Kong WJ
    Medicine (Baltimore); 2016 Dec; 95(52):e5767. PubMed ID: 28033296
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report).
    Silverstein H; Choo D; Rosenberg SI; Kuhn J; Seidman M; Stein I
    Ear Nose Throat J; 1996 Aug; 75(8):468-71, 474, 476 passim. PubMed ID: 8828271
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endolymphatic hydrops in Ménière's disease: cause, consequence, or epiphenomenon?
    Foster CA; Breeze RE
    Otol Neurotol; 2013 Sep; 34(7):1210-4. PubMed ID: 23921917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.